Live News Categoriesmarket

BSLN (BSLN) News

Follow BSLN (BSLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BSLN Asset market Sector Markets 90 days 1 Updated Sep 14, 2026, 05:21 AM UTC Open live news feed

L Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients Allschwil, Switzerland, September 14, 2026Basilea Pharmaceutica Ltd, Allschwil SIX:BSLN, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections NEWS | Sep 14, 2026, 05:21 AM UTC